KCM
NVO

KRS Capital Management’s Novo Nordisk NVO Stock Holding History

KRS Capital Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$216K Buy
+4,510
New +$194K 0.1% 117
2024
Q4 		– Sell
-1,745
Closed -$208K – 114
2024
Q3 		$208K Hold
1,745
– – 0.15% 113
2024
Q2 		$249K Hold
1,745
– – 0.19% 103
2024
Q1 		$224K Buy
+1,745
New +$208K 0.18% 110

Other funds holding NVO

SRIM
Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
QI
QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
OFA
Oak Family Advisors Chicago, Illinois $391M AUM 26.35% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

KRS Capital Management's NVO Position: Q2 2026 in Review

KRS Capital Management opened a new position in Novo Nordisk (NVO) in Q2 2026: 4,510 shares worth $216K. The stake represents 0.1% of the portfolio and ranks #117 among its holdings. This is a return to the name: KRS Capital Management previously reported a position in NVO as recently as Q3 2024.

KRS Capital Management first reported a position in NVO in Q1 2024 and has held it in 4 quarters since. The position peaked at $249K in Q2 2024. 387 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • KRS Capital Management held 4,510 shares of Novo Nordisk worth $216K as of Q2 2026.
  • Novo Nordisk was a new KRS Capital Management position in Q2 2026.
  • Novo Nordisk made up 0.1% of KRS Capital Management's portfolio in Q2 2026, its #117 holding.
  • KRS Capital Management first reported a position in Novo Nordisk in Q1 2024 and has held it in 4 quarters since.
  • KRS Capital Management's Novo Nordisk position peaked at $249K in Q2 2024.
  • 387 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on KRS Capital Management's 13F filing for Q2 2026, filed 20 Jul 2026.